The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

For those who need frequent blood draws or IV (intravenous) treatments, a port can make it easier to access a vein and reduce the number of needle pricks you receive. Most of us are familiar with ...